AMGN News 137.27 08/27/2014 04:33:04 Amgen Inc (AMGN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amgen Inc (AMGN) 137.27 $AMGN

7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
Brian Orelli, The Motley Fool - Motley Fool - Tue Aug 26, 8:56PM CDT
Regeneron Pharmaceuticals held a conference call earlier this month to highlight its second-quarter earnings and give investors some insight into the biotech's prospects for the rest of the year. Here are seven things management wants you to know....

Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 5:44PM CDT
Kite Pharma, Inc. (KITE) announced the publication of positive results from an ongoing phase I-IIa study on KTE-C19 for aggressive non-Hodgkin's lymphoma.

Final Glance: Biotechnology companies
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

HCP Boasts Of 29 Years Of Dividend Increases
at Investor's Business Daily - Tue Aug 26, 4:57PM CDT
HCP (HCP) is a real estate investment trust that invests in four health-care sectors: senior housing; post-acute/skilled nursing facilities; life sciences; and medical offices and hospitals. The company manages, acquires, develops and sells...

Regado Slumps on Permanent Termination of Revolixys Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 4:20PM CDT
Regado Biosciences (RGDO) announced that it is permanently terminating the enrollment process for its phase III study on Revolixys Kit.

VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 4:00PM CDT
VIVUS, Inc. (VVUS) announced that it has acquired certain patents related to Topamax from Janssen Pharmaceuticals, Inc.

Midday Glance: Biotechnology companies
AP - Tue Aug 26, 12:31PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

17.2% Return Seen to Date on SmarTrend Amgen Call (AMGN)
Comtex SmarTrend(R) - Tue Aug 26, 11:04AM CDT
SmarTrend identified an Uptrend for Amgen (NASDAQ:AMGN) on June 2nd, 2014 at $116.45. In approximately 3 months, Amgen has returned 17.16% as of today's recent price of $136.43.

Early Glance: Biotechnology companies
AP - Tue Aug 26, 10:12AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

3 Reasons Amgen Inc.'s Stock Could Fall
Sean Williams, The Motley Fool - Motley Fool - Tue Aug 26, 8:43AM CDT
Years of patience are finally paying off for Amgen shareholders, whose shares jump by more than 160% over the past three years. AMGN data by YCharts Amgen's shares have rallied on the prospect of delivering late-stage data on 10 new...

3 Reasons Celgene Corporation's Stock Could Fall
Sean Williams, The Motley Fool - Motley Fool - Tue Aug 26, 7:49AM CDT
If you've been a long-term shareholder in Celgene stock you have very little to complain about. The company's core drug, Revlimid, a treatment for blood-borne cancers, has grown into what's expected to be a $5 billion blockbuster this year, and...

'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - Tue Aug 26, 4:00AM CDT
The trading panel looked at banks and the top buy and sell candidates for right now.

Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 5:25PM CDT
The EMA accepted Cubist Pharmaceuticals' (CBST) MAA for its investigational antibiotic, ceftolozane/tazobactam.

Amgen Set to Possibly Pullback After Yesterday's Rally of 1.48%
Comtex SmarTrend(R) - Mon Aug 25, 3:53PM CDT
Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $133.38 to a high of $134.93. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $133.46 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.48% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Aug 25, 3:53PM CDT
Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $133.38 to a high of $134.93. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $133.46 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Timothy Leyden Retires As Western Digital CFO, Succeeded By Olivier Leonetti Of Amgen And Formerly At Dell
PR Newswire - Mon Aug 25, 3:15PM CDT
Western Digital Corp. (NASDAQ: WDC) today announced that chief financial officer Tim Leyden, 62, is retiring after 24 years of distinguished service at the company. He is being succeeded by Olivier Leonetti, 50, who has served as vice president, finance at Amgen Inc. from 2011, after having previously spent 14 years in global finance leadership positions at Dell Inc. Leyden will remain with the company through January 2015 in a transition role and advisory capacity to president and chief executive officer Steve Milligan and to Leonetti for an interim period to ensure a smooth transition. The changes are effective as of September 8, 2014.

Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday

Kindred Biosciences Falls on Disappointing CereKin Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 8:22AM CDT
Shares of Kindred Biosciences, Inc. (KIN) plunged 28.2% as a pivotal field study on its pipeline candidate CereKin (interleukin-1 inhibitor) failed to meet the primary endpoint.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 128

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 81

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 141

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 47

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 81

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 144

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 144

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
Inhabit Puts AI Across Its Property Management Stack

Updated Category News Views 37

Property managers do not need another shiny chatbot; they need fewer dropped leads, fewer invoice-entry mistakes and less staff time burned chasing routine answers. That is the sensible hook in Inhabit's OPTECH 2026 announcement. The company is spreading AI, integrations and scalability work across ResMan, Anyone Home, ePremium, Nationwide Compliant and several adjacent...

Continue Reading

Top 5 Most Recently Viewed Articles

Skylark Labs Enhances Mobility Analytics with New Contracts

Updated Category News Views 259

Transforming Mobility Analytics Skylark Labs is at the forefront of innovation as it takes significant strides to transform mobility analytics. The company recently announced its success in securing multiple contracts aimed at deploying its advanced Scout Towers throughout busy highways. Empowering the Indiana DOT The focus of these contracts is primarily on empowering...

Continue Reading
Arm Collaborates with Malaysia on $250 Million Chip Initiative

Updated Category News Views 201

Introduction to the Exciting Partnership Arm Holdings – ADR (NASDAQ: ARM), a dynamic subsidiary of SoftBank Group Corp. (OTC: SFTBY), has embarked on a groundbreaking partnership with Malaysia, sealing a monumental $250 million deal. This agreement aims to significantly enhance chip design and technology services over the next decade, marking a pivotal moment in both...

Continue Reading
Music Licensing, Inc. (OTC: SONG) Implements New Share Classes

Updated Category News Views 119

Music Licensing, Inc. Unveils New Share Classes and Forward Stock Split Music Licensing, Inc. (OTC: SONG), a well-known leader in music rights management, is making substantial moves to improve its stock market standing. Recently, the company faced some challenges, including an unsuccessful reverse stock split. In response to these hurdles, they are proactively addressing...

Continue Reading
Exploring Legal Actions for Venture Global, Inc. Investors

Updated Category News Views 368

Latest Developments for Venture Global, Inc. Investors Venture Global, Inc. is currently under scrutiny as a class-action lawsuit has been initiated on behalf of its investors. This follows significant developments surrounding the company's operations and interactions with major clients. Understanding the Class Action Lawsuit The lawsuit focuses on the concerns raised by...

Continue Reading
STL and Colt Together Pioneer Multi-Core Fibre Trials for The Future

Updated Category News Views 112

Innovation in Optical Connectivity: The STL and Colt Collaboration In a groundbreaking development, STL (NSE: STLTECH), a renowned connectivity solutions provider, has successfully partnered with Colt Technology Services to conduct trials of their innovative Multi-Core Fibre (MCF). This initiative, executed within Colt's expansive optical network in an urban setting,...

Continue Reading